中国P站

Anti-inflammatory diet; Cancer prevention; Nutritional oncology; Chronic inflammation; Dietary antioxidants; Plant-based nutrition; Whole foods; Omega-3 fatty acids; Dietary fiber; Immune modulation; Nutrigenomics; Functional foods; Cancer risk reduction; Phytochemicals; Lifestyle intervention

Introduction

Cancer is a multifactorial disease influenced by genetic, environmental, and lifestyle factors, among which diet plays a significant role. Chronic inflammation is recognized as a key contributor to the development and progression of various cancers. In this context, anti-inflammatory nutrition has emerged as a promising dietary approach to reduce cancer risk. An anti-inflammatory diet emphasizes the consumption of whole, unprocessed foods rich in antioxidants, phytochemicals, and healthy fats while minimizing pro-inflammatory foods such as processed meats, refined carbohydrates, and trans fats [1-5]. Numerous epidemiological and experimental studies suggest that such dietary patterns can reduce systemic inflammation, improve immune function, and modulate molecular pathways involved in carcinogenesis. The incorporation of anti-inflammatory foods into daily nutrition represents a practical and sustainable strategy for cancer prevention. This approach aligns with global health recommendations that encourage the adoption of diets rich in fruits, vegetables, whole grains, legumes, nuts, and fatty fish as part of a comprehensive lifestyle intervention aimed at reducing the burden of non-communicable diseases, including cancer [6-10].

Discussion

The biological mechanism linking chronic inflammation to cancer involves persistent activation of immune responses, which may result in DNA damage, increased cellular proliferation, and angiogenesis, all of which contribute to tumor initiation and progression. Diets high in pro-inflammatory components such as red meat, processed sugars, and saturated fats have been shown to elevate inflammatory Maykers like C-reactive protein, interleukin-6, and tumor necrosis factor-alpha. In contrast, anti-inflammatory diets can suppress these Maykers and promote protective biological responses. Key components of an anti-inflammatory diet include omega-3 fatty acids from fatty fish and flaxseeds, polyphenols from berries, green tea, and turmeric, and dietary fiber from whole grains and legumes. These nutrients possess antioxidant properties that neutralize free radicals, reduce oxidative stress, and modulate gene expression associated with inflammation and cell cycle regulation.

In the field of nutritional oncology, the role of diet in cancer prevention is supported by growing evidence from cohort studies and clinical trials. For instance, the Mediterranean diet, which is rich in anti-inflammatory foods, has been associated with reduced incidence of breast, colorectal, and prostate cancers. Similarly, plant-based diets, when properly balanced, can provide essential nutrients while limiting exposure to carcinogens often found in processed animal products. Nutrigenomics research further supports the concept that dietary compounds can influence gene expression, potentially turning off pro-cancer pathways and activating tumor-suppressive mechanisms.

Functional foods such as fermented vegetables, probiotic-rich yogurt, and spices like ginger and garlic contribute to a balanced gut microbiome, which in turn regulates immune responses and inflammation. Micronutrients such as vitamins A, C, D, E, and minerals like zinc and selenium play crucial roles in cellular defense systems. Adopting an anti-inflammatory dietary pattern is not only beneficial for cancer prevention but also supports overall metabolic health, weight management, and cardiovascular protection, which are important for reducing cancer risk.

Public health strategies that promote anti-inflammatory nutrition must also address accessibility, cultural preferences, and behavioral change. Nutrition education, food labeling, and policy-driven interventions such as subsidies for healthy food options can help increase adherence to cancer-preventive diets. Collaboration between healthcare providers, dietitians, and community organizations is essential for implementing effective dietary interventions, particularly in high-risk populations.

While dietary interventions cannot entirely eliminate cancer risk, they serve as an important modifiable factor that complements genetic screening, lifestyle changes, and clinical surveillance. Anti-inflammatory nutrition also plays a role in survivorship care, where reducing inflammation may improve recovery, treatment outcomes, and quality of life for cancer patients.

Conclusion

Anti-inflammatory nutrition offers a scientifically supported and practical approach to cancer risk reduction. By targeting chronic inflammation—a recognized contributor to carcinogenesis—this dietary model promotes the intake of nutrient-dense, minimally processed foods that support immune health and metabolic balance. Emphasizing the regular consumption of anti-inflammatory foods, such as leafy greens, berries, whole grains, fatty fish, and legumes, can significantly reduce inflammatory bioMaykers and potentially lower the incidence of several types of cancer. As part of a broader lifestyle strategy that includes physical activity, stress reduction, and avoidance of tobacco and excessive alcohol, anti-inflammatory nutrition contributes to a comprehensive cancer prevention framework. Moving forward, greater awareness, access to healthy food, and interdisciplinary collaboration are key to integrating anti-inflammatory dietary practices into public health and clinical guidelines. Ultimately, empowering individuals with knowledge and resources to make informed dietary choices can lead to a healthier population and reduced cancer burden globally.

References

1. Bianca B, Hergen S (2006). Annu Rev Immunol 24: 287-320.

, ,

1. Travlos GS (2006). Toxicol Pathol 34: 548-565.

, ,

1. Kampen KR (2012). Leuk Res 36: 6-13.

, ,

1. Weir EG, Borowitz MJ (2001). Semin Hematol 38: 124-138.

, ,

1. Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, et al. (2020). Int J Mol Sci 21:1054.

, ,

1. Grewal A (2011). J Anaesthesiol Clin Pharmacol. 27: 297-302.

, ,

1. Ingrande J, Lemmens HJM (2010). Br J Anaesth 105: i16-i23.

, ,

1. Kaur M, Singh PM (2011). Anesth Essays Res 5: 128-133.

, ,

1. Peng K, Liu HY, Wu SR, Cheng H, Ji FH, et al. (2015). Clin J Pain 31: 1097-1104.

, ,

1. Venn RM, Karol MD, Grounds RM (2002). Br J Anaesth 88: 669-675.

, ,